Knowledge hub

Blog

Gut microbiota’s road to clinical utilization. From bathroom to bedside.

Off-the-Shelf allogeneic cellular immunotherapies for cancer
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Ardigen obtained a Great Place to Work certification
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors
Conformal Prediction in Classification
Ardigen and OncoArendi join forces for research collaboration
Cross validation – a safeguard for machine learning models
Machine Learning on its road to conquer Microbiome Research
News

Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery

Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
Happy Easter holiday
Reaching beneath the tip of the iceberg: Discovering the potential of TCR-T therapies in treating cancer
DVC – Data Version Control System
Dr. Michał Warchoł has joined the company’s Board of Management as its 4th member
When metabolome meets microbiome
CAR-T cell therapies: limitations and improvement strategies
An image says more than a thousand words in biomedical applications